ea0026p46 | Endocrine disruptors | ECE2011
Doknic M
, Bojovic N Maric
, Pekic S
, Britvic D
, Damjanovic A
, Gasic M Jasovic
, Popovic V
Introduction: Studies suggest that schizophrenia and prolactin raising antipsychotics, one of them being risperidone, may be associated with low bone mass. On the other hand, weight gain as a consequence of antipsychotics in these patients may be the protective factor against osteoporosis.Objective: Determine bone remodeling parameters and bone mass in patients with schizophrenia treated with long-acting injectable risperidone (LAIR) under naturalistic c...